Home Table of Contents

§ 2-803. Approved cannabidiol for use in clinical trials

Oklahoma Statutes AnnotatedTitle 63. Public Health and Safety

Oklahoma Statutes Annotated
Title 63. Public Health and Safety (Refs & Annos)
Chapter 2. Uniform Controlled Dangerous Substances Act (Refs & Annos)
Article VII. Clinical Trials
63 Okl.St.Ann. § 2-803
§ 2-803. Approved cannabidiol for use in clinical trials
A. Clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to the provisions of this act shall only utilize cannabidiol which is:
1. From an approved source; and
2. Approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application.
B. The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the clinical trials.


Laws 2015, c. 203, § 5, emerg. eff. April 30, 2015.
63 Okl. St. Ann. § 2-803, OK ST T. 63 § 2-803
Current with emergency effective legislation through Chapter 332 of the Second Regular Session of the 59th Legislature (2024). Some sections may be more current, see credits for details.
End of Document